2022
DOI: 10.1016/j.jaad.2021.04.075
|View full text |Cite
|
Sign up to set email alerts
|

Cost efficacy of wide local excision of pT1a melanoma in office versus operating room settings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
5
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(6 citation statements)
references
References 2 publications
1
5
0
Order By: Relevance
“…MMS and CE-Office demonstrated lower costs than CE-OR in the institutional (MMS $2092.95, CE-Office $1376.45, CE-OR $2856.87) and insurance claims (MMS $2882.25, CE-Office $2043.98, CE-OR $5122.19) cohorts, which upholds previous findings describing the lower cost of outpatient surgery for melanoma 13 and nonmelanoma 17–19 skin cancer treatment. For example, Duncan and colleagues 13 found that reimbursements for pT1a melanoma treated with CE-OR and CE-Office were $2,612 and $1,419 respectively, although tumor location and surgical technique were not described. For outpatient surgery, MMS was more expensive than CE-Office in our cohort.…”
Section: Discussionsupporting
confidence: 67%
See 4 more Smart Citations
“…MMS and CE-Office demonstrated lower costs than CE-OR in the institutional (MMS $2092.95, CE-Office $1376.45, CE-OR $2856.87) and insurance claims (MMS $2882.25, CE-Office $2043.98, CE-OR $5122.19) cohorts, which upholds previous findings describing the lower cost of outpatient surgery for melanoma 13 and nonmelanoma 17–19 skin cancer treatment. For example, Duncan and colleagues 13 found that reimbursements for pT1a melanoma treated with CE-OR and CE-Office were $2,612 and $1,419 respectively, although tumor location and surgical technique were not described. For outpatient surgery, MMS was more expensive than CE-Office in our cohort.…”
Section: Discussionsupporting
confidence: 67%
“…If these additional costs were included, our results may be similar to the results of older literature describing comparable costs 11,16 for MMS and CE-POMA in skin cancer treatment. Further research is needed to account for the 19) cohorts, which upholds previous findings describing the lower cost of outpatient surgery for melanoma 13 and nonmelanoma [17][18][19] skin cancer treatment. For example, Duncan and colleagues 13 found that reimbursements for pT1a melanoma treated with CE-OR and CE-Office were $2,612 and $1,419 respectively, although tumor location and surgical technique were not described.…”
Section: Discussionmentioning
confidence: 57%
See 3 more Smart Citations